Skip to main content
. 2024 Jun 11;25(12):6433. doi: 10.3390/ijms25126433
ACMS3 Acyl-CoA synthetase medium-chain 3
AMPK AMP-activated protein kinase
AR Androgen receptor
BMI Body mass index
CAA Cancer-associated adipocytes
Cav-1 Caveolin-1
CM Cutaneous melanoma
CRP C-reactive protein
ER Estrogen receptor
FAs Fatty acids
FASN Fatty acid synthase
FFA Free fatty acid
ICI Immune checkpoint inhibitor
IGF-1 Insulin-like growth factor-1
IL-1 Interleukin-1
IL-6 Interleukin-6
IL-18 Interleukin-18
irAEs Immune-related adverse events
LEF-1 Lymphoid enhancer-binding factor 1
LDL Low-density lipoproteins
mTOR Mammalian target of rapamycin
OS Overall survival
PD-1 Programmed cell death protein 1
PD-L1 Programmed death-ligand 1
PFS Progression-free survival
PPARα Peroxisome proliferator-activated receptor alpha
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
ROS Reactive oxygen species
TME Tumor microenvironment
TNF-α Tumor necrosis factor alpha
TNM Tumor, Node, Metastasis
TREM2 Triggering receptor expressed on myeloid cells 2
VEGF Vascular endothelial growth factor
Wnt5a Wnt family member 5A
β-cat Beta-catenin